Avoiding surgery for thyroid eye disease
Author:
- 4 October 2006
- journal article
- clinical trial
- Published by Springer Nature in Eye
- Vol. 20 (10) , 1171-1177
Abstract
In thyroid eye disease, autoimmune inflammation of orbital musculature and fat increases the bulk of the orbital contents. Orbital tension rises and patients stratify according to the ease with which their globes can proptose. Restriction of proptosis is associated with optic nerve compression and visual loss; exophthalmos, with corneal damage. Ocular motility is affected, initially by muscle inflammation; late in the disease, by fibrosis. Extraocular factors, including thyroid endocrine disturbance, antigen release, infections, malignancies, and smoking, may trigger and drive the orbital myopathy. The management of thyroid eye disease by the identification and treatment of drives, followed by immunomodulatory therapy, is discussed. Fourteen patients with compressive optic neuropathy were treated with immunomodulation using intravenous methylprednisolone, oral prednisolone, and cyclosporin A, and followed up for a minimum of three years. All recovered their pre-morbid visual acuities and visual fields in both eyes. Severe disturbances of ocular motility also recovered in 30 patients, treated with the same regime. In one subject, ocular motility normalised with intravenous steroids and cyclosporin A, but no oral prednisolone. Morbidity from the treatment was low. Immunomodulation is a rational and successful method for managing optic nerve compression and disordered motility in this condition.Keywords
This publication has 10 references indexed in Scilit:
- Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves’ OphthalmopathyInvestigative Ophthalmology & Visual Science, 2005
- Relationship between management of hyperthyroidism and course of the ophthalmopathyJournal of Endocrinological Investigation, 2004
- Unlocking the immunological mechanisms of orbital inflammation in thyroid eye diseaseClinical and Experimental Immunology, 2002
- Pathogenesesis of Ophthalmopathy in Autoimmune Thyroid DiseaseReviews in Endocrine and Metabolic Disorders, 2000
- Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophagesRespiratory Medicine, 1998
- The Thyrotropin Receptor in Thyroid Eye DiseaseThyroid®, 1998
- The Mechanism of Action of Cyclosporin A and FK506Clinical Immunology and Immunopathology, 1996
- Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapseQJM: An International Journal of Medicine, 1994
- POSITIVE REGULATION OF HUMAN THYROTROPIN RECEPTOR mRNA BY THYROTROPINThe Journal of Clinical Endocrinology & Metabolism, 1991
- Functional Scoring of the Field of Binocular Single VisionOphthalmology, 1990